heparin


Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

hep·a·rin

 (hĕp′ər-ĭn)
n.
1. An acidic glycosaminoglycan found especially in lung and liver tissue and having the ability to slow the clotting of blood, used as a drug in the treatment of thrombosis. Also called unfractionated heparin.
2. Any of several anticoagulants, such as enoxaparin, that are derived from this compound by depolymerization and have a lower molecular weight and somewhat different pharmacological properties. Also called low-molecular-weight heparin.

[Late Latin hēpar, liver (from Greek; see yē̆kw in Indo-European roots) + -in.]

heparin

(ˈhɛpərɪn)
n
(Biochemistry) a polysaccharide, containing sulphate groups, present in most body tissues: an anticoagulant used in the treatment of thrombosis
[C20: from Greek hēpar the liver + -in]
ˈheparinˌoid adj

hep•a•rin

(ˈhɛp ə rɪn)

n.
a polysaccharide present in animal tissues, esp. the liver, that has anticoagulant properties and is used to prevent or dissolve blood clots.
[1915–20; < Greek hêpar liver + -in1]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.heparin - a polysaccharide produced in basophils (especially in the lung and liver) and that inhibits the activity of thrombin in coagulation of the blood; it (trade names Lipo-Hepin and Liquaemin) is used as an anticoagulant in the treatment of thrombosis and in heart surgery
anticoagulant, anticoagulant medication, decoagulant - medicine that prevents or retards the clotting of blood
polyose, polysaccharide - any of a class of carbohydrates whose molecules contain chains of monosaccharide molecules
Translations

hep·a·rin

n. heparina, sustancia que actúa como anticoagulante.

heparin

n heparina; low-molecular-weight — heparina de bajo peso molecular
References in periodicals archive ?
Pharmaceutical company Mylan NV (NASDAQ:MYL) (TASE:MYL) revealed on Friday the receipt of final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for Heparin Sodium Injection USP, 1,000 USP/ml, 5,000 USP/ml, 10,000 USP/ml and 20,000 USP/ml.
Delayed hypersensitivity reactions to subcutaneously injected heparin are relatively common and present as eczematous plaques at injection sites (Anders & Trautmann, 2013).
USA], Sep 06 ( ANI ): A medication widely used to prevent blood clotting, heparin, can now be used as a potential target drug to regulate appetite and weight control, suggests a recent study.
00, plus prejudgment interest, for the attorneys' fees and litigation expenses the insureds had incurred to defend themselves against the heparin litigation between January 18, 2009 and June 14, 2016.
Both heparin and low-molecular-weight-heparins (LMWHs) are injectable subcutaneously, which will always create issues with regards to patient compliance and can carry the risk of hematoma and more seriously, heparininduced thrombocytopenia (HIT).
Visit the Heparin Anticoagulant Market 2013-2020 report at https://www.
One strategy to minimise or eliminate the requirement for systemic heparin administration involves coating the ECC with heparin prior to connecting the patient to reduce the risk of clotting within the circuit (Frank et al.
Currently, it is known that heparin resistance is one of the reasons for arterial thrombosis.
This contract is for the supply of pharmaceutical specialties: Low molecular weight heparin - parenteral nutrition peripherally.
On day 11, argatroban was initiated in lieu of heparin, however, the patient died on day 14 from initial exposure to heparin.
Heparin group (group H) who received Heparin flush solution and 0.
KEY WORDS: Activated coagulation time Cell saver Coagulopathy Heparin.